Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer


NCT00004236

Interventional

Phase 2

Unknown status
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of liposomal doxorubicin in treating patients who have advanced stomach cancer.
Aug 31,1998
All
18 Years
N/A

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.